4//SEC Filing
Murphy Matthew B. 4
Accession 0001808805-22-000093
CIK 0001808805other
Filed
Aug 15, 8:00 PM ET
Accepted
Aug 16, 8:19 PM ET
Size
7.1 KB
Accession
0001808805-22-000093
Insider Transaction Report
Form 4
Murphy Matthew B.
General Counsel
Transactions
- Purchase
Common Stock
2022-08-15$2.84/sh+7,500$21,308→ 54,140 total(indirect: See Footnote) - Purchase
Common Stock
2022-08-12$2.85/sh+2,500$7,125→ 46,640 total(indirect: See Footnote)
Holdings
- 1,250
Common Stock
Footnotes (2)
- [F1]Shares held by the Murphy Family Trust. The reporting person is the Trustee of the Murphy Family Trust.
- [F2]1,250 shares of Common Stock acquired on June 1, 2022 through the Issuer's 2021 Employee Stock Purchase Plan.
Documents
Issuer
Nautilus Biotechnology, Inc.
CIK 0001808805
Entity typeother
Related Parties
1- filerCIK 0001865778
Filing Metadata
- Form type
- 4
- Filed
- Aug 15, 8:00 PM ET
- Accepted
- Aug 16, 8:19 PM ET
- Size
- 7.1 KB